Apyx Medical Corp
APYXNasdaq
$4.28
↓ -1.4%Jul 17 close · end-of-day
Price
1Y↑ +104.8%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$187.2M
Enterprise Value
$191.2M
P/E
—
P/S
3.3
P/B
14.6
EV/EBITDA
—
PEG
—
FCF Yield
-4.8%
Dividend Yield
—
Revenue (TTM)
$55.9M
Net Income (TTM)
-$9.2M
Free Cash Flow (TTM)
-$9.0M
Gross Margin
63.1%
Operating Margin
-7.7%
Net Margin
-16.4%
ROE
-71.5%
ROIC
-20.3%
Debt / Equity
2.7
Net Cash
-$4.0M
Return 1Y
+87.7%
Company profile
Apyx Medical Corporation offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation.
- CEO
- Charles D. Goodwin
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 270
- Headquarters
- Florida
- Website
- apyxmedical.com
Management & directors
- Roman Shawn DavidChief Operating Officer
- Citronowicz MosheSenior Vice President
Roles derived from SEC Form 4 filings.
Earnings
APYX Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$12.5M↑ +32.4%
Diluted EPS——
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $27.7M | $48.5M | $44.5M | $52.3M | $48.1M | $52.8M |
| Gross profit | $17.5M | $33.6M | $29.1M | $33.8M | $29.4M | $33.0M |
| Operating income | -$20.1M | -$14.4M | -$23.6M | -$17.3M | -$18.8M | -$6.4M |
| Net income | -$11.9M | -$15.2M | -$23.2M | -$18.7M | -$23.5M | -$11.2M |
| Diluted EPS | -$0.35 | -$0.44 | -$0.67 | -$0.54 | — | — |
| Operating cash flow | -$16.1M | -$10.4M | -$20.3M | -$5.2M | -$18.0M | -$8.0M |
| Free cash flow | -$16.6M | -$11.2M | -$21.3M | -$5.8M | -$18.8M | -$9.1M |
| Gross margin | 63.2% | 69.3% | 65.4% | 64.5% | 61.0% | 62.5% |
| Operating margin | -72.5% | -29.8% | -52.9% | -33.0% | -39.2% | -12.2% |
| Net margin | -42.9% | -31.3% | -52.1% | -35.7% | -48.8% | -21.2% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.1M | $11.5M | $14.2M | $9.4M | $11.4M | $12.9M | $19.2M | $12.5M |
| Gross profit | $7.5M | $7.0M | $9.0M | $5.7M | $7.1M | $8.3M | $12.0M | $7.9M |
| Operating income | -$5.5M | -$3.6M | -$3.0M | -$3.1M | -$2.6M | -$832,000.00 | $11,000.00 | -$911,000.00 |
| Net income | -$6.6M | -$4.7M | -$4.6M | -$4.2M | -$3.8M | -$2.0M | -$1.3M | -$2.1M |
| Diluted EPS | -$0.19 | — | — | — | — | — | — | — |
| Operating cash flow | -$4.3M | -$4.4M | -$2.9M | -$702,000.00 | -$1.2M | -$3.5M | -$2.5M | -$572,000.00 |
| Free cash flow | -$4.6M | -$4.6M | -$3.2M | -$757,000.00 | -$1.5M | -$4.1M | -$2.8M | -$632,000.00 |
| Gross margin | 61.7% | 60.5% | 63.0% | 60.1% | 62.3% | 64.4% | 62.6% | 63.5% |
| Operating margin | -45.7% | -31.6% | -21.4% | -32.4% | -22.6% | -6.5% | 0.1% | -7.3% |
| Net margin | -54.0% | -40.9% | -32.5% | -44.0% | -33.2% | -15.4% | -6.8% | -16.9% |
Company news
May 21, 2026
- 60d agoWhat to Know About This Fund's $13.9 Million Exit From a Skyrocketing AI Power Playfool.com
- 60d agoOceaneering Stock Is Up 105% in a Year, and One Fund Just Disclosed a $7 Million Bet on More Growthfool.com
- 60d agoWhat to Know About This Fund's $9 Million Exit From a Pawn Shop Giant Up Nearly 150% This Past Yearfool.com
- 60d agoThis Satellite Company Grew Revenue 80%. One Fund Just Disclosed Buying $6 Million Worth of Sharesfool.com
- 60d agoNew Study Shows Significant Improvement in Cellulite and Skin Laxity with Advanced Minimally Invasive Treatment Utilizing Avéli® and Renuvion®finance.yahoo.com
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | Waldman Lawrence | Option exercise | 12,000 | $1.88 | $22,560.00 | filing |
| 2026-06-30 | Waldman Lawrence | Tax withholding | 5,024 | $4.49 | $22,557.76 | filing |
| 2026-06-15 | Roman Shawn David· Chief Operating Officer | Tax withholding | 10,533 | $4.60 | $48,451.80 | filing |
| 2026-06-15 | Roman Shawn David· Chief Operating Officer | Option exercise | 15,000 | $3.23 | $48,450.00 | filing |
| 2026-06-11 | Vizirgianakis Stavros G. | Award | 450,000 | $0.00 | $0.00 | filing |
| 2026-03-15 | CITRONOWICZ MOSHE· Senior Vice President | Option exercise | 37,000 | $1.80 | $66,600.00 | filing |
| 2026-01-27 | Roman Shawn David· Chief Operating Officer | Option exercise | 12,000 | $1.80 | $21,600.00 | filing |
Latest 7 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.